140 related articles for article (PubMed ID: 36848658)
1. MnOOH-Catalyzed Autoxidation of Glutathione for Reactive Oxygen Species Production and Nanocatalytic Tumor Innate Immunotherapy.
Zhu P; Pu Y; Wang M; Wu W; Qin H; Shi J
J Am Chem Soc; 2023 Mar; 145(10):5803-5815. PubMed ID: 36848658
[TBL] [Abstract][Full Text] [Related]
2. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy.
Su G; Xu H; Zhou F; Gong X; Tan S; He Y
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444
[TBL] [Abstract][Full Text] [Related]
3. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
4. Bimetallic oxide nanozyme-mediated depletion of glutathione to boost oxidative stress for combined nanocatalytic therapy.
Li S; Ding H; Chang J; Dong S; Shao B; Dong Y; Gai S; He F; Yang P
J Colloid Interface Sci; 2022 Oct; 623():787-798. PubMed ID: 35636288
[TBL] [Abstract][Full Text] [Related]
5. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
[TBL] [Abstract][Full Text] [Related]
6. Peroxidase-like Active Nanomedicine with Dual Glutathione Depletion Property to Restore Oxaliplatin Chemosensitivity and Promote Programmed Cell Death.
Wu F; Du Y; Yang J; Shao B; Mi Z; Yao Y; Cui Y; He F; Zhang Y; Yang P
ACS Nano; 2022 Mar; 16(3):3647-3663. PubMed ID: 35266697
[TBL] [Abstract][Full Text] [Related]
7. Bioinspired nanocatalytic tumor therapy by simultaneous reactive oxygen species generation enhancement and glutamine pathway-mediated glutathione depletion.
Mao H; Wen Y; Yu Y; Li H; Wang J; Sun B
J Mater Chem B; 2022 Dec; 11(1):131-143. PubMed ID: 36484247
[TBL] [Abstract][Full Text] [Related]
8. Mild-temperature responsive nanocatalyst for controlled drug release and enhanced catalytic therapy.
Xu M; Xie X; Liu Y; Topham PD; Zeng Y; Zhan J; Wang L; Yu Q
Acta Biomater; 2023 Sep; 167():473-488. PubMed ID: 37271248
[TBL] [Abstract][Full Text] [Related]
9. Engineering 2D Cu-composed metal-organic framework nanosheets for augmented nanocatalytic tumor therapy.
Zhuang S; Xiang H; Chen Y; Wang L; Chen Y; Zhang J
J Nanobiotechnology; 2022 Feb; 20(1):66. PubMed ID: 35120548
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
[TBL] [Abstract][Full Text] [Related]
11. Photothermal-reinforced and glutathione-triggered in Situ cascaded nanocatalytic therapy.
An P; Fan F; Gu D; Gao Z; Hossain AMS; Sun B
J Control Release; 2020 May; 321():734-743. PubMed ID: 32145265
[TBL] [Abstract][Full Text] [Related]
12. Precisely designed Fe
Meng Y; Zhang D; Song Y; Yang X; Gao Y; Ma J; Hu Z; Zheng X
Nanoscale; 2023 Feb; 15(5):2305-2315. PubMed ID: 36636960
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.
Zhu L; Dai Y; Gao L; Zhao Q
Int J Nanomedicine; 2021; 16():4559-4577. PubMed ID: 34267513
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
15. Dual Size/Charge-Switchable Nanocatalytic Medicine for Deep Tumor Therapy.
Wu W; Pu Y; Shi J
Adv Sci (Weinh); 2021 May; 8(9):2002816. PubMed ID: 33977044
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
18. A Metal-Organic Framework (MOF) Fenton Nanoagent-Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition.
Yang B; Ding L; Yao H; Chen Y; Shi J
Adv Mater; 2020 Mar; 32(12):e1907152. PubMed ID: 32053261
[TBL] [Abstract][Full Text] [Related]
19. Manganese-enriched photonic/catalytic nanomedicine augments synergistic anti-TNBC photothermal/nanocatalytic/immuno-therapy via activating cGAS-STING pathway.
Zheng Y; Chen J; Song XR; Chang MQ; Feng W; Huang H; Jia CX; Ding L; Chen Y; Wu R
Biomaterials; 2023 Feb; 293():121988. PubMed ID: 36580716
[TBL] [Abstract][Full Text] [Related]
20. Correction to "MnOOH-Catalyzed Autoxidation of Glutathione for Reactive Oxygen Species Production and Nanocatalytic Tumor Innate Immunotherapy".
Zhu P; Pu Y; Wang M; Wu W; Qin H; Shi J
J Am Chem Soc; 2023 May; 145(18):10441-10442. PubMed ID: 37125836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
